Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy.

BACKGROUND Significant analytic variability exists between the multiple assays for cardiac troponin I (cTnI) approved for clinical use. Until adequate cTnI standardization is possible, an evidence-based approach evaluating each assay at specific thresholds appears warranted. METHODS We examined the efficacy of three cTnI assays for predicting death, myocardial infarction (MI), or the composite of death, MI, or urgent revascularization at 43 days among patients with non-ST-elevation acute coronary syndromes enrolled in the Thrombolysis In Myocardial Infarction (TIMI) 11B study. RESULTS Six hundred eighty-one patients with serum samples obtained at baseline and/or 12-24 h had cTnI determined using all three assays. Baseline cTnI was > or = 0.1 microg/L for 368, 395, and 418 patients with the Bayer Immuno 1(TM), ACS:180, and Dimension RxL assays, respectively. Correlation coefficients for the RxL with the ACS:180 and Bayer Immuno 1 results were 0.89 (P = 0.0001) and 0.87 (P = 0.0001), with a coefficient of 0.92 (P = 0.0001) for the ACS:180 and Bayer Immuno 1 assays. Patients with cTnI > or = 0.1 microg/L were at increased risk fo death or MI by 43 days (relative risk, 2.2-3.0; P <0.0006), regardless of the assay used. This prognostic capacity persisted among those with creatine kinase MB isoenzyme concentrations within the reference interval. Moreover, cTnI was the strongest multivariate predictor of death, MI, or urgent revascularization with adjusted odds ratios of 2.1-2.9 (P <0. 0006). CONCLUSION This study demonstrates the prognostic efficacy of three independently developed cTnI assays at a threshold of 0.1 microg/L for the prediction of adverse clinical outcomes among patients with non-ST-elevation acute coronary syndromes.

[1]  Ric,et al.  CARDIAC TROPONIN T LEVELS FOR RISK STRATIFICATION IN ACUTE MYOCARDIAL ISCHEMIA , 2000 .

[2]  Eorge,et al.  CARDIAC-SPECIFIC TROPONIN I LEVELS TO PREDICT THE RISK OF MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES , 2000 .

[3]  E. Antman,et al.  Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. , 1999, Circulation.

[4]  W. Gibler,et al.  National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. , 1999, Clinical chemistry.

[5]  M. Zhang,et al.  Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays. , 1999, Clinical chemistry.

[6]  J. Tate,et al.  The lack of standardization of cardiac troponin I assay systems. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[7]  E. Antman,et al.  The role of cardiac Troponin‐I (cTnI) in risk stratification of patients with unstable coronary artery disease , 1999, Clinical cardiology.

[8]  F. Apple,et al.  Clinical and analytical standardization issues confronting cardiac troponin I. , 1999, Clinical chemistry.

[9]  L. Voipio‐Pulkki,et al.  Degradation of cardiac troponin I: implication for reliable immunodetection. , 1998, Clinical chemistry.

[10]  D. Waters,et al.  Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies. , 1998, The American journal of cardiology.

[11]  A. Wu,et al.  Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. , 1998, Clinical chemistry.

[12]  R. Califf,et al.  Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes , 1998 .

[13]  R. Califf,et al.  Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. , 1998, Clinical chemistry.

[14]  C. Heeschen,et al.  Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. , 1997, The New England journal of medicine.

[15]  S W Sharkey,et al.  Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I. , 1997, Clinical chemistry.

[16]  K. Thygesen,et al.  Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia. , 1997, Circulation.

[17]  P. Allen,et al.  Troponin I phosphorylation in the normal and failing adult human heart. , 1997, Circulation.

[18]  K. Pulkki,et al.  Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. , 1997, Clinical chemistry.

[19]  A. Jaffe,et al.  Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. , 1997, Circulation.

[20]  M. Preece,et al.  Measurement of lactate in cerebrospinal fluid in investigation of inherited metabolic disease. , 1997, Clinical chemistry.

[21]  V. Gökhan Cin,et al.  The prognostic value of serum troponin T in unstable angina. , 1996, International journal of cardiology.

[22]  F. Harrell,et al.  Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. , 1996, The New England journal of medicine.

[23]  F. Apple,et al.  Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. , 1995, Clinical chemistry.

[24]  A. Wu,et al.  Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction. , 1994, Clinical chemistry.

[25]  Jack H. Ladenson,et al.  Cardiac Troponin I A Marker With High Specificity for Cardiac Injury , 1993, Circulation.

[26]  K. Linnet,et al.  Evaluation of regression procedures for methods comparison studies. , 1993, Clinical chemistry.

[27]  A. Remppis,et al.  Diagnostic Efficiency of Troponin T Measurements in Acute Myocardial Infarction , 1991, Circulation.

[28]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.